rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lourdes Felix

Director

Company insider

Files Form 4 as: Director, Lixte Biotechnology Holdings; Director, Avalon GloboCare; Director, La Rosa Holdings; CEO and CFO, BioCorRx.

Every Form 4 they filed

In numbers

Trades disclosed
43
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
4
Companies where not an officer
3
First trade
28 Nov 2012
Last trade
1 Jul 2026
Last filed
13 Jul 2026

Companies traded

Where they are an officer
BioCorRxDirector, Officer · last 31 Dec 20240 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Lixte Biotechnology HoldingsDirector · Biotechnology · last 1 Jul 20260 buys · 0 sells
Avalon GloboCareDirector · IT Services & Consulting · last 29 Jun 20260 buys · 0 sells
La Rosa HoldingsDirector · RE Services & Developers · last 11 Aug 20250 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
1 Jul 2026filed 2 Jul 2026Lixte Biotechnology HoldingsBiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
1 Jul 2026filed 2 Jul 2026NMAD Nomad Power SolutionsBiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
29 Jun 2026filed 13 Jul 2026Avalon GloboCareoption or derivative · IT Services & ConsultingSEC FORM 4 Code A—100,000 at $0.00filing
29 Jun 2026filed 13 Jul 2026CHGA Change Agentsoption or derivative · IT Services & ConsultingSEC FORM 4 Code A—100,000 at $0.00filing
15 Apr 2026filed 17 Apr 2026Lixte Biotechnology HoldingsBiotechnologySEC FORM 4 Code A—25,000filing
15 Apr 2026filed 17 Apr 2026Lixte Biotechnology Holdingsoption or derivative · BiotechnologySEC FORM 4 Code D—25,000filing
15 Apr 2026filed 17 Apr 2026NMAD Nomad Power Solutionsoption or derivative · BiotechnologySEC FORM 4 Code D—25,000filing
15 Apr 2026filed 17 Apr 2026NMAD Nomad Power SolutionsBiotechnologySEC FORM 4 Code A—25,000filing
24 Dec 2025filed 29 Dec 2025NMAD Nomad Power Solutionsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
11 Aug 2025filed 18 Aug 2025La Rosa HoldingsRE Services & DevelopersSEC FORM 4 Code A—600 at $0.00filing
31 Dec 2024filed 31 Jan 2025BioCorRxSEC FORM 4 Code A—13,158 at $0.00filing
30 Sep 2024filed 31 Jan 2025BioCorRxSEC FORM 4 Code A—15,625 at $0.00filing
2 Jul 2024filed 31 Jan 2025BioCorRxSEC FORM 4 Code A—500,000 at $0.00filing
28 Jun 2024filed 8 Jul 2024BioCorRxSEC FORM 4 Code A—10,204 at $0.00filing
24 Apr 2024filed 31 Jan 2025BioCorRxSEC FORM 4 Code A—224,196 at $0.00filing
28 Mar 2024filed 3 Apr 2024BioCorRxSEC FORM 4 Code A—5,566 at $0.00filing
2 Jan 2024filed 4 Jan 2024BioCorRxSEC FORM 4 Code A—6,173 at $0.00filing
29 Sep 2023filed 2 Oct 2023BioCorRxSEC FORM 4 Code A—2,858 at $0.00filing
30 Jun 2023filed 5 Jul 2023BioCorRxSEC FORM 4 Code A—2,891 at $0.00filing
31 Mar 2023filed 3 Apr 2023BioCorRxSEC FORM 4 Code A—2,824 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.